Hip Arthroscopy Often Not the Best Option for Older Patients

This article originally appeared here.
Share this content:
Hip Arthroscopy Often Not the Best Option for Older Patients
Hip Arthroscopy Often Not the Best Option for Older Patients

MONDAY, June 6, 2016 (HealthDay News) -- Many patients in their 60s who have hip arthroscopy need total hip arthroplasty (THA) within two years, according to research published in the April issue of Arthroscopy: The Journal of Arthroscopic and Related Surgery.

William Schairer, M.D., of the Hospital for Special Surgery in New York City, and colleagues reviewed information from two surgical databases. One was in California, the other was in Florida. The investigators identified 7,351 patients who'd had hip arthroscopy and at least two years of medical follow-up. The mean age of the patients was 44, and 58.8 percent of the group was female.

The researchers found that, overall, 11.7 percent of patients had THA within two years of having a hip arthroscopy. Patients who had hip arthroscopy in hospitals that performed a high volume of those procedures were less likely to need THA within two years. The researchers also found other risk factors that increased the odds of needing THA. These included older age (over 60), obesity, or osteoarthritis. Rates of THA were lowest in patients under 40.

"Hip arthroscopy is performed in patients of various ages, including middle-aged and elderly patients," the authors write. "Older patients have a higher rate of conversion to THA, as do patients with osteoarthritis or obesity."

Abstract
Full Text (subscription or payment may be required)
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Higher Fish Intake Appears to Reduce RA Symptoms

Higher Fish Intake Appears to Reduce RA Symptoms

Researchers suggest most varieties of fish may play a role in controlling symptoms

Longer Survival for Midostaurin  Chemotherapy in AML With FLT3

Longer Survival for Midostaurin + Chemotherapy in AML ...

Prolonged overall, event-free survival for patients with acute myeloid leukemia, FLT3 mutation

HIV Testing Inadequate in Young Men Who Have Sex With Men

HIV Testing Inadequate in Young Men Who Have ...

Only 28 percent of young MSM have HIV testing, though they account for 83 percent of new diagnoses

is free, fast, and customized just for you!

Already a member?

Sign In Now »